Terms: = Bone cancer AND H3F3A, P84243, H3_3B, MGC87783, MGC87782, H3F3, H3_3A, ENSG00000163041, 3020
105 results:
1. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1.
Adachi Y; Noguchi R; Yoshimatsu Y; Sin Y; Osaki J; Ono T; Iwata S; Akiyama T; Tsuchiya R; Toda Y; Ishihara S; Ogura K; Kobayashi E; Kojima N; Yoshida A; Yokoo H; Kawai A; Kondo T
Hum Cell; 2024 May; 37(3):874-885. PubMed ID: 38466561
[TBL] [Abstract] [Full Text] [Related]
2. Giant Cell Tumor of the Acromion: Case Report and Literature Review.
Sano J; Chijiiwa Y; Nishio J
In Vivo; 2024; 38(1):506-510. PubMed ID: 38148094
[TBL] [Abstract] [Full Text] [Related]
3. [Giant cell tumor of bone-an update].
Tschavoll F; Lutteri G; Leinauer B; Mellert K; Möller P; Barth TFE
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):215-219. PubMed ID: 37985483
[TBL] [Abstract] [Full Text] [Related]
4. Cycle-generative adversarial network-based bone suppression imaging for highly accurate markerless motion tracking of lung tumors for cyberknife irradiation therapy.
Mochizuki Z; Saito M; Suzuki T; Mochizuki K; Hasegawa J; Nemoto H; Satani K; Takahashi H; Onishi H
J Appl Clin Med Phys; 2024 Jan; 25(1):e14212. PubMed ID: 37985163
[TBL] [Abstract] [Full Text] [Related]
5. Osteosarcoma's genetic landscape painted by genes' mutations.
Urban W; Krzystańska D; Piekarz M; Nazar J; Jankowska A
Acta Biochim Pol; 2023 Sep; 70(3):671-678. PubMed ID: 37717265
[TBL] [Abstract] [Full Text] [Related]
6. Adult granulosa cell tumor of the testis with malignant tendency: A case report with genetic analysis using high-throughput sequencing.
Deng L; Zeng J; Qiu JF; Yang LH; Ma J
Medicine (Baltimore); 2023 Aug; 102(32):e34523. PubMed ID: 37565864
[TBL] [Abstract] [Full Text] [Related]
7. h3f3a mutation as a marker of malignant giant cell tumor of the bone: A case report and review of literature.
Ratnagiri R; Uppin S
J Cancer Res Ther; 2023; 19(3):832-834. PubMed ID: 37470622
[TBL] [Abstract] [Full Text] [Related]
8. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone.
Ono T; Noguchi R; Yoshimatsu Y; Sin Y; Tsuchiya R; Akiyama T; Kojima N; Toda Y; Sato C; Fukushima S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2023 Sep; 36(5):1804-1812. PubMed ID: 37328637
[TBL] [Abstract] [Full Text] [Related]
9. Multicentric Giant Cell Tumor of bone.
Errani C; Tsukamoto S; Angulo Alvarado R; Righi A; Nitta Y; Donati DM; Mavrogenis AF
Orthopedics; 2023; 46(6):e376-e380. PubMed ID: 37126833
[TBL] [Abstract] [Full Text] [Related]
10. [Giant cell tumour of bone in the rib cage treated with denosumab. A case report].
Serret Miralles P; Orellana Fernández R; Parra Parente T; García-Chamón Brígido RB; Carrera Salas R
Rev Esp Patol; 2023; 56(2):119-123. PubMed ID: 37061238
[TBL] [Abstract] [Full Text] [Related]
11. Giant cell tumor of bone with h3f3B mutation: A case report.
Wu R; Wu X; Weng X; Xiu Y; Xu G; Liu X; Liu X
Medicine (Baltimore); 2023 Feb; 102(7):e32995. PubMed ID: 36800629
[TBL] [Abstract] [Full Text] [Related]
12. Giant-cell-poor giant cell tumor of bone: report of two cases and literature review.
Yakoub MA; Torrence D; Hwang S; Bartelstein M; Healey JH; Hameed M
Skeletal Radiol; 2023 Sep; 52(9):1791-1798. PubMed ID: 36781420
[TBL] [Abstract] [Full Text] [Related]
13. Chondroblastoma: clinicopathological analyses of 307 cases from a single institution in China and the diagnostic value of the h3f3 K36M mutant antibody.
Zhao Q; Tang J; Luo Y; Huang J; Hu D; Zhu J; Jiang T; Zhang H; Liu Z
J Clin Pathol; 2023 Jun; 76(6):367-373. PubMed ID: 36604179
[TBL] [Abstract] [Full Text] [Related]
14. bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
Fanburg-Smith JC; Smith JD; Flemming DJ
Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
[TBL] [Abstract] [Full Text] [Related]
15. Prognosis of patients with unresectable stage IV Colon cancer undergoing primary tumor resection: A multicenter study of minimally symptomatic or asymptomatic primary tumor.
Ho MF; Lai VC; Ng DCK; Ng SSM
Asian J Surg; 2023 Sep; 46(9):3710-3715. PubMed ID: 36522225
[TBL] [Abstract] [Full Text] [Related]
16. Blue lacy matrix in giant cell tumour of bone with or without denosumab therapy.
Toda Y; Ishihara S; Kawai A; Yoshida A
Virchows Arch; 2023 Jul; 483(1):125-129. PubMed ID: 36447097
[TBL] [Abstract] [Full Text] [Related]
17. Malignant Transformation of Giant Cell Tumour of bone: A Review of Literature and the Experience of a Referral Centre.
Vari S; Riva F; Onesti CE; Cosimati A; Renna D; Biagini R; Baldi J; Zoccali C; Anelli V; Annovazzi A; Covello R; Ascione A; Casini B; Ferraresi V
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142631
[TBL] [Abstract] [Full Text] [Related]
18. The Activation of PDGFRβ on Mononuclear Stromal/Tumor Cells in Giant Cell Tumor of bone After Denosumab Treatment. An Immunohistochemical Study of Five Cases.
Antal I; Pápai Z; Szendrői M; Perlaky T; Dezső K; Lippai Z; Sápi Z
Pathol Oncol Res; 2022; 28():1610633. PubMed ID: 36091939
[TBL] [Abstract] [Full Text] [Related]
19. Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India.
Kamble A; Hui M; Rao KN; Narayanan R; Reddy BR; Uppin SG; Chandrasekhar P
Indian J Pathol Microbiol; 2022; 65(3):617-629. PubMed ID: 35900490
[TBL] [Abstract] [Full Text] [Related]
20. Updated concepts in treatment of giant cell tumor of bone.
van der Heijden L; Lipplaa A; van Langevelde K; Bovée JVMG; van de Sande MAJ; Gelderblom H
Curr Opin Oncol; 2022 Jul; 34(4):371-378. PubMed ID: 35837707
[TBL] [Abstract] [Full Text] [Related]
[Next]
